☆ 4.7 Article

Evaluation of tumor antigen-specific antibody responses in patients with metastatic triple negative breast cancer treated with cyclophosphamide and pembrolizumab

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer

Carey K. Anders et al.

Summary: This study evaluated the efficacy of using a low dose of cyclophosphamide (Cy) to deplete regulatory T cells (T-regs) before initiating pembrolizumab in patients with triple negative breast cancer (TNBC). The results showed that Cy did not significantly decrease T-regs before pembrolizumab and there was a rapid recovery in T-regs after the first cycle of therapy. Baseline samples with increased B cell gene expression were associated with clinical response and immune-related toxicity (IRT).

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

添加到收藏夹

Article Immunology

Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing cells in renal cell cancer

Maxime Meylan et al.

Summary: The presence of intratumoral tertiary lymphoid structures (TLS) is associated with positive clinical outcomes and responses to immunotherapy in renal cell carcinoma (RCC). B cells are enriched in TLS and demonstrate diverse maturation stages, with the presence of fully mature clonotypes. Additionally, IgG-and IgA-producing plasma cells (PCs) disseminate into the tumor beds along fibroblastic tracks in TLS+ tumors, indicating potential anti-tumor effector activity. Furthermore, the presence of IgG-stained tumor cells correlates with therapeutic responses and progression-free survival in RCC patients treated with immune checkpoint inhibitors.

IMMUNITY (2022)

添加到收藏夹

Article Oncology

Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer study

Dominik A. Barth et al.

Summary: This prospective study aimed to evaluate the association between autoantibodies in the serum of cancer patients and immune-checkpoint inhibitor (ICI) therapy response and immune-related adverse events (irAEs). The results showed that there was no significant association between the presence of autoantibodies and treatment efficacy or higher grade irAEs, neither at treatment start nor after 8-12 weeks of ICI treatment.

CANCER MEDICINE (2022)

添加到收藏夹

Article Oncology

Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade

Paul Johannet et al.

Summary: This study found that baseline serum autoantibody signatures predicted recurrence and severe toxicity in patients treated with adjuvant immunotherapy.

CLINICAL CANCER RESEARCH (2022)

添加到收藏夹

Article Medicine, General & Internal

Chemotherapy-Induced, Broadly Reactive Autoantibodies in a Colon Cancer Patient

Felix Broecker et al.

Summary: The link between cancer and autoimmunity is well-known. Chemotherapy can induce broad autoimmune responses, but monitoring self-reactive IgM responses may help reduce adverse events.

CUREUS JOURNAL OF MEDICAL SCIENCE (2022)

添加到收藏夹

Review Oncology

Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities

Celine M. Laumont et al.

Summary: Tumour-infiltrating B cells and plasma cells have a crucial role in tumour control, promoting antitumour immunity through unique antigen presentation, assembling and perpetuating immunologically 'hot' tumour microenvironments, combating immune editing and tumour heterogeneity.

NATURE REVIEWS CANCER (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses

Can Cui et al.

Summary: The study found that the enrichment of TFH cell transcriptional signature in lung adenocarcinoma patients is correlated with GC B cell signature and prolonged survival. Interactions between tumor-specific TFH and GC B cells are crucial for tumor control and effector CD8 T cell function.

CELL (2021)

添加到收藏夹

Article Multidisciplinary Sciences

IgA transcytosis and antigen recognition govern ovarian cancer immunity

Subir Biswas et al.

Summary: Most ovarian cancers are infiltrated by activated T cells that have prognostic relevance, but they show low response rates to immune checkpoint inhibitors. On the contrary, memory B cell and plasma cell infiltrates associated with better outcomes may exert protective effects against tumor cells through B cell-derived IgA in ovarian cancer.

NATURE (2021)

添加到收藏夹

Review Oncology

Anti-Cancer Auto-Antibodies: Roles, Applications and Open Issues

Hugo de Jonge et al.

Summary: Cancer is a leading cause of death worldwide, making early detection crucial for effective treatment. Auto-antibodies, circulating antibodies specific for tumor cells, have the potential to impact tumor growth and may be utilized for cancer management. However, their significance and role in cancer progression still require further research.

CANCERS (2021)

添加到收藏夹

Article Oncology

Beneficial autoimmunity improves cancer prognosis

Laurence Zitvogel et al.

Nature Reviews Clinical Oncology (2021)

添加到收藏夹

Article Oncology

Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression

Lucile Vanhersecke et al.

Summary: The presence of mature tertiary lymphoid structures is associated with improved response to immunotherapy in cancer patients, predicting objective response rates, progression-free survival, and overall survival. These findings support the potential use of TLS detection to select patients who are more likely to benefit from immune checkpoint blockade.

NATURE CANCER (2021)

添加到收藏夹

Article Multidisciplinary Sciences

B cells are associated with survival and immunotherapy response in sarcoma

Florent Petitprez et al.

NATURE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Tertiary lymphoid structures improve immunotherapy and survival in melanoma

Rita Cabrita et al.

NATURE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

B cells and tertiary lymphoid structures promote immunotherapy response

Beth A. Helmink et al.

NATURE (2020)

添加到收藏夹

Article Oncology

Autoantibody Landscape in Patients with Advanced Prostate Cancer

William S. Chen et al.

CLINICAL CANCER RESEARCH (2020)

添加到收藏夹

Article Immunology

The Antigen Presenting Potential of CD21low B Cells

Marlene E. Reincke et al.

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Article Oncology

Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment

Stefan Diem et al.

JOURNAL OF IMMUNOTHERAPY (2019)

添加到收藏夹

Article Biochemical Research Methods

NeoPredPipe: high-throughput neoantigen prediction and recognition potential pipeline

Ryan O. Schenck et al.

BMC BIOINFORMATICS (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer

Daniel P. Hollern et al.

CELL (2019)

添加到收藏夹

Article Oncology

Autoantibody Development under Treatment with Immune-Checkpoint Inhibitors

Emma C. de Moel et al.

CANCER IMMUNOLOGY RESEARCH (2019)

添加到收藏夹

Article Oncology

Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality

Rick L. Evans et al.

BMC CANCER (2018)

添加到收藏夹

Article Medicine, Research & Experimental

Early B cell changes predict autoimmunity following combination immune checkpoint blockade

Rituparna Das et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

添加到收藏夹

Article Medicine, Research & Experimental

Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors

Michael F. Gowen et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2018)

添加到收藏夹

Article Immunology

Intravenous Cyclophosphamide Therapy for Anti-IFN-Gamma Autoantibody-Associated Mycobacterium abscessus Infection

Ploenchan Chetchotisakd et al.

JOURNAL OF IMMUNOLOGY RESEARCH (2018)

添加到收藏夹

Article Medicine, Research & Experimental

Autoantibody-producing plasmablasts after B cell depletion identified in muscle-specific kinase myasthenia gravis

Panos Stathopoulos et al.

JCI INSIGHT (2017)

添加到收藏夹

Article Oncology

Protective effect of naturally occurring anti-HER2 autoantibodies on breast cancer

Yukiko Tabuchi et al.

BREAST CANCER RESEARCH AND TREATMENT (2016)

添加到收藏夹

Article Genetics & Heredity

dbNSFP v3.0: A One-Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice-Site SNVs

Xiaoming Liu et al.

HUMAN MUTATION (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses

Kelly D. Moynihan et al.

NATURE MEDICINE (2016)

添加到收藏夹

Article Oncology

Eps8 regulates cellular proliferation and migration of breast cancer

Cheng Chen et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2015)

添加到收藏夹

Article Biochemical Research Methods

OptiType: precision HLA typing from next-generation sequencing data

Andras Szolek et al.

BIOINFORMATICS (2014)

添加到收藏夹

Review Immunology

Oncology Meets Immunology: The Cancer-Immunity Cycle

Daniel S. Chen et al.

IMMUNITY (2013)

添加到收藏夹

Article Biochemistry & Molecular Biology

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

Kai Wang et al.

NUCLEIC ACIDS RESEARCH (2010)

添加到收藏夹

Review Hematology

B lymphocytes: how they develop and function

Tucker W. LeBien et al.

BLOOD (2008)

添加到收藏夹

Review Immunology

Autoantibodies to tumor-associated antigens: reporters from the immune system

Eng M. Tan et al.

IMMUNOLOGICAL REVIEWS (2008)

添加到收藏夹

Article Oncology

Autoantibodies in breast cancer: their use as an aid to early diagnosis

C. Chapman et al.

ANNALS OF ONCOLOGY (2007)

添加到收藏夹

Article Medicine, General & Internal

Autoantibody signatures in prostate cancer

XJ Wang et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

添加到收藏夹

Article Genetics & Heredity

The exchangeability of amino acids in proteins

LY Yampolsky et al.

GENETICS (2005)

添加到收藏夹

Article Oncology

Antibodies to HSP70 and HSP90 in serum in non-small cell lung cancer patients

L Zhong et al.

CANCER DETECTION AND PREVENTION (2003)

添加到收藏夹

Article Medicine, Research & Experimental

Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis

EM Tan

JOURNAL OF CLINICAL INVESTIGATION (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.